Back to Search Start Over

Vasorelaxant effect of water fraction of Labisia Pumila and its mechanisms in spontaneously hypertensive rats aortic ring preparation.

Authors :
Manshor NM
Razali N
Jusoh RR
Asmawi MZ
Mohamed N
Zainol S
Altaf R
Dewa A
Source :
International Journal of Cardiology. Hypertension [Int J Cardiol Hypertens] 2020 Jan 11; Vol. 4, pp. 100024. Date of Electronic Publication: 2020 Jan 11 (Print Publication: 2020).
Publication Year :
2020

Abstract

Introduction: Labisia pumila has been reported to possess activities including antioxidant, anti-aging and anti-cancer but there is no report on its vasorelaxant effects.<br />Objective: This study aims to fractionate water extract of Labisia pumila , identify the compound(s) involved and elucidate the possible mechanism(s) of its vasorelaxant effects.<br />Methods: Water extract of Labisia pumila was subjected to liquid-liquid extraction to obtain ethyl acetate, n-butanol and water fractions. In SHR aortic ring preparations, water fraction (WF-LPWE) was established as the most potent fraction for vasorelaxation. The pharmacological mechanisms of the vasorelaxant effect of WF-LPWE were investigated with and without the presence of various inhibitors. The cumulative dose-response curves of potassium chloride (KCl)-induced contractions were conducted to study the possible mechanisms of WF-LPWE in reducing vasoconstriction.<br />Results: WF-LPWE produced dose-dependent vasorelaxant effect in endothelium-denuded aortic ring and showed non-competitive inhibition of dose-response curves of PE-induced contraction, and at its higher concentrations reduced KCl-induced contraction. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) significantly inhibited vasorelaxant effect of WF-LPWE. WF-LPWE significantly reduced the release of intracellular calcium ion (Ca <superscript>2+</superscript> ) from the intracellular stores and suppressed the calcium chloride (CaCal <subscript>2</subscript> )-induced contraction. N <superscript>ω</superscript> -nitro-L-arginine methyl ester (L-NAME), methylene blue, indomethacin and atropine did not influence the vasorelaxant effects of WF-LPWE.<br />Conclusion: WF-LPWE exerts its vasorelaxant effect independently of endothelium and possibly by inhibiting the release of calcium from intracellular calcium stores, receptor-operated calcium channels and formation of inositol 1,4,5- triphosphate. WF-LPWE vasorelaxant effect may also mediated via nitric oxide-independent direct involvement of soluble guanylate cyclase (sGC)/ cyclic guanosine monophosphate (cGMP) pathways.<br />Competing Interests: We wish to inform that there is no known conflict of interest associated with this publication.<br /> (© 2020 Published by Elsevier B.V.)

Details

Language :
English
ISSN :
2590-0862
Volume :
4
Database :
MEDLINE
Journal :
International Journal of Cardiology. Hypertension
Publication Type :
Academic Journal
Accession number :
33447753
Full Text :
https://doi.org/10.1016/j.ijchy.2020.100024